LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr | ₹-31 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-57 Cr |
Mar2023 | ₹-37 Cr |
Mar2022 | ₹-78 Cr |
Mar2021 | ₹-64 Cr |
Mar2020 | ₹-31 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-57 Cr | Negative | |
Mar2023 | ₹-37 Cr | Negative | |
Mar2022 | ₹-78 Cr | Negative | |
Mar2021 | ₹-64 Cr | Negative | |
Mar2020 | ₹-31 Cr | - |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,043.4 Cr | -6.8% | -30.4% | -15.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -6.8% |
-30.4% |
-15.7% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses